Key result
Minimally invasive mitral valve surgery linked to ~79% lower 30-day mortality vs sternotomy in older patients.
Why the study?
Older patients are more prone to postoperative morbidity and mortality after mitral valve surgery, and the potential benefits of minimally invasive MV surgery in this population require evaluation.
Does minimally invasive mitral valve surgery improve short-term mortality and morbidity compared to sternotomy in patients aged 70 years and older undergoing primary elective mitral valve surgery?
Cohort (n=1,418)
Yes
Does minimally invasive mitral valve surgery improve short-term mortality and morbidity compared to sternotomy in patients aged 70 years and older undergoing primary elective mitral valve surgery?
In older adults undergoing primary mitral valve surgery, a minimally invasive approach was associated with substantially lower 30-day mortality and morbidity than median sternotomy, while maintaining comparable 5-year survival.
Answers are grounded in this paper and cite their sources.
May support minimally invasive mitral valve surgery in elderly patients; leaves open need for randomized confirmation before practice change.
OBJECTIVES: Older patients are more prone to postoperative morbidity and mortality after mitral valve (MV) surgery. Minimally invasive MV surgery (MIMVS) is increasingly adopted worldwide, with a potential benefit in the elderly. This study compares short-term and mid-term outcomes in patients above 70 years, undergoing MIMVS versus median sternotomy (MST), in a nationwide registry. METHODS: All patients above 70 years undergoing primary elective MV surgery (±tricuspid valve [TV] surgery, atrial septal defect closure, rhythm surgery) between 2013 and 2021 were included. All data were extracted from the Netherlands Heart Registration. Primary outcomes were short-term morbidity, mortality, and 5-year survival. RESULTS: In total, 1418 patients were included (MST n = 797, MIMVS n = 621). No statistically significant differences in baseline characteristics were found. Median Logistic EuroSCORE I was 6.3 [4.7-8.5] vs 6.0 [4.6-8.5], P = .27 for MST and MIMVS, respectively. Mitral valve repair (77.7% vs 64.7% P < .001) and concomitant TV surgery (43.9% vs 18.2%, P < .001) was more frequently performed in MST. Lower 30-day mortality was observed in MIMVS (0.6% [n = 4] vs 2.5% [n = 21], P = .01). Furthermore, the incidence of pneumonia, prolonged intubation, readmission to intensive care unit, kidney failure, and new-onset arrhythmia were lower for MIMVS. No difference in 5-year survival was found (MST: 89.1 ± 4.6% vs MIMVS: 91.6 ± 4.7% Log-Rank P = .51). CONCLUSIONS: Minimally invasive MV surgery in patients above 70 years may be associated with lower 30-day mortality and incidence of postoperative complications compared with sternotomy.
No takes yet. Share an insight, caveat, or question.
Tjien et al. (2026) conducted a cohort in Mitral valve disease requiring primary elective surgery (n=1,418). Minimally invasive mitral valve surgery (MIMVS) vs. Median sternotomy (MST) was evaluated on 30-day mortality (OR 0.21, 95% CI 0.07-0.63, p=0.01). Minimally invasive mitral valve surgery in patients older than 70 years was associated with lower 30-day mortality compared to sternotomy.
Synapse has enriched 10 related papers. Consider them for comparative context: